All-trans retinoic acid enhances in vitro mesenchymal stem cells migration by targeting matrix metalloproteinases 2 and 9

Biotechnology letters · 2017 · vol. 39(8) , pp. 1263–1268 · doi:10.1007/s10529-017-2350-1 · PMID:28488074
Lab / animal OA: closed
View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-21 ⓘ

All-trans retinoic acid enhances rat mesenchymal stem cell migration by upregulating matrix metalloproteinase 2 and 9 expression while inhibiting caspase 3 activity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: To investigate the effect of all-trans retinoic acid (ATRA) on caspase 3 activity, matrix metalloproteinase 2 (MMP-2), and MMP-9 expression and activity as well as in vitro rat bone marrow-derived mesenchymal stem cells (MSCs) migration. RESULTS: The expression of the MMP-2/-9 was at least five times higher in ATRA-treated MSCs (P < 0.001), and MMP-2/-9 activity was enhanced with increasing doses compared to the control MSCs. The caspase three activity was attenuated by ATRA preconditioning. Scratch test showed that ATRA could promote the migration capacity of the MSCs compared to the untreated MSCs in a dose-dependent manner. CONCLUSION: ATRA increases the in vitro migration capacity of the MSCs through stimulating the expression and activity of MMP-2/-9 and inhibiting caspase three enzyme activity.

My notes (saved in your browser only)

MeSH descriptors

Cell Movement Matrix Metalloproteinase 2 Matrix Metalloproteinase 9 Mesenchymal Stem Cells Mesenchymal Stem Cells Tretinoin Animals Caspase 3 Caspase 3 Cell Movement Male Matrix Metalloproteinase 2 Matrix Metalloproteinase 9 Mesenchymal Stem Cells Rats Rats, Wistar Tretinoin

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:19:54.474666+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00